01/16/2007 Vicus Therapeutics Announces FDA Approval of Phase 2 Trial of VT-122 for the Treatment of Cachexia in Patients With Advanced Lung Cancer ...View press release

11/20/2006 Vicus Therapeutics to Host Webinar on Repurposing Drugs to Create Proprietary Cancer Products ... View press release

10/16/2006 Vicus Therapeutics Signs Strategic Services Agreement with Leading Indian Clinical Research Organization .... View press release